MS Therapy Management for Pregnancy May Raise Relapse Risk



(MedPage Today) — Management of disease-modifying therapies (DMTs) for multiple sclerosis (MS) during pregnancy raised relapse risk, especially for certain drugs, French registry data suggested.
Across all MS drugs, DMT management during pregnancy…



Source link : https://www.medpagetoday.com/neurology/multiplesclerosis/116818

Author :

Publish date : 2025-08-04 19:13:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version